All News
Filter News
Found 808,651 articles
-
ArthroCare Corporation Flips Loss to Net $7.3M Gain in Q2
8/4/2010
-
Shire Pharmaceuticals Delivers Excellent Q2 Performance With Total Revenues Up 35%. Full Year Earnings Expectations Raised
8/4/2010
-
Molecular Bandit Keeps Pain at Bay, University of North Carolina Study
8/4/2010
-
Fructose Encourages Pancreatic Cancer Growth, University of California, Los Angeles (UCLA) Study
8/4/2010
-
STAAR Surgical Company Continues Year-Over-Year Revenue Growth During Second Quarter of 2010
8/4/2010
-
Screening Newly Arrived Immigrants From Countries Where TB Is Endemic Does Not Work And Should Be Scrapped, UK
8/4/2010
-
Neoprobe Corporation Sets Sights on NYSE, AMEX Stock Exchange Listing
8/4/2010
-
B Vitamins Do Not Appear to Lower Risk for Subsequent Vascular Events After Stroke or TIA
8/4/2010
-
BrainCells Inc. Grabs Neuropsych Therapy from Proximagen Group in $51M Licensing Pact
8/4/2010
-
Sperm May Be Harmed By Exposure To BPA, University of Michigan Study Suggests
8/4/2010
-
Sanofi-Aventis (France) Owners Oppose Big Hike To $19B Genzyme Corporation Bid
8/4/2010
-
US Dietary Supplements Not As Safe As Consumers Might Assume
8/4/2010
-
Hepatitis B Linked To Lymphoma In National Cancer Institute and Sun Ha Jee of Yonsei University Study
8/4/2010
-
In Pivotal Phase III Studies, Merck & Co., Inc.'s Investigational Medicine Boceprevir Helped Majority of Patients with Chronic Hepatitis C Genotype 1 Infection Achieve Sustained Virologic Response, the Primary Endpoint of the Studies
8/4/2010
-
Diabetes Drug Spurs Weight Loss, Better Cardiac Profile
8/4/2010
-
Isis Pharmaceuticals, Inc., Genzyme Corporation Cholesterol Drug Meets Study Goals; Meet Primary Endpoints with 36 and 37 Percent LDL-C Reductions in Severe Hypercholesterolemia and High-Risk Patients
8/4/2010
-
Biotech Horizon Biopharm Files To Sell Up To $86.3 Mln In IPO
8/4/2010
-
Two Pharma Giants, Sanofi-Aventis (France), Genzyme Corporation Employ 600 in Ireland
8/4/2010
-
Should Tuberculosis (TB)-Preventive Therapy (IPT) Be Given To All?
8/4/2010
-
Lux Biosciences Receives Complete Response Letter from FDA for Luveniq(TM)
8/4/2010